BEGIN:VCALENDAR VERSION:2.0 CALSCALE:GREGORIAN METHOD:PUBLISH PRODID://CGC//515167 BEGIN:VEVENT DTSTAMP:20260410T152215 VTIMEZONE:America/New_York DTSTART:20260520T190000Z DTEND:20260520T200000Z UID:515167 SUMMARY:Coffee Break with CGC Mentor - Lu Wang, MD, PhD, FACMG LOCATION: DESCRIPTION:Coffee Break with CGC Mentor - Lu Wang, MD, PhD, FACMG\n\n05/20/26 03:00 PM EST\n - 05/20/26 04:00 PM EST\Description:\nAre you a trainee or early-career (1-3 years after training) CGC member looking to broaden your perspective by making professional connections with colleagues at different institutions? Do you have questions related to your training or career development, or would you find it helpful to speak with an expert CGC member in your field who can provide guidance and insight? If so, we invite you to join us for the CGC Early Career Initiative Committee’s 2026 Coffee Break with CGC Mentors, an opportunity to connect with experienced professionals, ask questions, and build meaningful relationships within the CGC community.\n\nWednesday, May 20, 3:00 - 4:00pm EDT / 2:00 - 3:00pm CDT / 12:00 - 1:00pm PDT\nLu Wang, MD, PhD, FACMG, is an Associate Member Molecular Pathologist and the Medical Director of Molecular Pathology in the Department of Pathology at St. Jude Children’s Research Hospital (SJCRH). Dr. Wang is a board-certified clinical molecular geneticist and cancer cytogeneticist. She received her MD and PhD degrees from Shandong Univ. Cheeloo College of Medicine and Shanghai Institute of Hematology, Shanghai Jiao Tong Univ. School of Medicine in China, and completed her post-graduate training at Weill Medical College of Cornell University and Memorial Sloan Kettering Cancer Center (MSKCC) in New York City.\n\nDr. Wang had been a faculty member in the Department of Pathology at MSKCC from 2010 to 2017, and joined the faculty at SJCRH in late 2017. Her clinical-translational research focuses on leukemia genomics/genetics and genomic profiling of rare tumors with an emphasis on clinical translation of potential diagnostic markers and therapeutic targets as well as clinical tests development. Dr. Wang’s lab-based research focuses on functional characterization of oncogenic gene fusions. Dr. Wang also actively collaborate with researchers locally, nationally and internationally, providing molecular genetics/genomics expertise to clinical consultations and to a variety of research projects. Dr. Wang has authored 100+ peer-reviewed original research articles as well as ~20 additional publications including cases reports, invited reviews and commentary and book chapters.\n                     \n\nPotential Discussion Topics:\n\n\n Build a career as clinician-scientist to advance molecular diagnostics \n\n X-ALT-DESC;FMTTYPE=text/html:Coffee Break with CGC Mentor - Lu Wang, MD, PhD, FACMG

05/20/26 03:00 PM EST - 05/20/26 04:00 PM EST
Description:
Are you a trainee or early-career (1-3 years after training) CGC member looking to broaden your perspective by making professional connections with colleagues at different institutions? Do you have questions related to your training or career development, or would you find it helpful to speak with an expert CGC member in your field who can provide guidance and insight? If so, we invite you to join us for the CGC Early Career Initiative Committee’s 2026 Coffee Break with CGC Mentors, an opportunity to connect with experienced professionals, ask questions, and build meaningful relationships within the CGC community.

Wednesday, May 20, 3:00 - 4:00pm EDT / 2:00 - 3:00pm CDT / 12:00 - 1:00pm PDT

Lu Wang, MD, PhD, FACMG, is an Associate Member Molecular Pathologist and the Medical Director of Molecular Pathology in the Department of Pathology at St. Jude Children’s Research Hospital (SJCRH). Dr. Wang is a board-certified clinical molecular geneticist and cancer cytogeneticist. She received her MD and PhD degrees from Shandong Univ. Cheeloo College of Medicine and Shanghai Institute of Hematology, Shanghai Jiao Tong Univ. School of Medicine in China, and completed her post-graduate training at Weill Medical College of Cornell University and Memorial Sloan Kettering Cancer Center (MSKCC) in New York City.

Dr. Wang had been a faculty member in the Department of Pathology at MSKCC from 2010 to 2017, and joined the faculty at SJCRH in late 2017. Her clinical-translational research focuses on leukemia genomics/genetics and genomic profiling of rare tumors with an emphasis on clinical translation of potential diagnostic markers and therapeutic targets as well as clinical tests development. Dr. Wang’s lab-based research focuses on functional characterization of oncogenic gene fusions. Dr. Wang also actively collaborate with researchers locally, nationally and internationally, providing molecular genetics/genomics expertise to clinical consultations and to a variety of research projects. Dr. Wang has authored 100+ peer-reviewed original research articles as well as ~20 additional publications including cases reports, invited reviews and commentary and book chapters.
                     

Potential Discussion Topics:

PRIORITY:3 TRANSP:TRANSPARENT BEGIN:VALARM TRIGGER:-PT5M ACTION:DISPLAY DESCRIPTION:Reminder END:VALARM END:VEVENT END:VCALENDAR